TY - JOUR
T1 - Short chain fatty acids
T2 - Microbial metabolites for gut-brain axis signalling
AU - O'Riordan, Kenneth J.
AU - Collins, Michael K.
AU - Moloney, Gerard M.
AU - Knox, Emily G.
AU - Aburto, María R.
AU - Fülling, Christine
AU - Morley, Shane J.
AU - Clarke, Gerard
AU - Schellekens, Harriët
AU - Cryan, John F.
N1 - Publisher Copyright:
© The Authors
PY - 2022/4/15
Y1 - 2022/4/15
N2 - The role of the intestinal microbiota as a regulator of gut-brain axis signalling has risen to prominence in recent years. Understanding the relationship between the gut microbiota, the metabolites it produces, and the brain will be critical for the subsequent development of new therapeutic approaches, including the identification of novel psychobiotics. A key focus in this regard have been the short-chain fatty acids (SCFAs) produced by bacterial fermentation of dietary fibre, which include butyrate, acetate, and propionate. Ongoing research is focused on the entry of SCFAs into systemic circulation from the gut lumen, their migration to cerebral circulation and across the blood brain barrier, and their potential to exert acute and chronic effects on brain structure and function. This review aims to discuss our current mechanistic understanding of the direct and indirect influence that SCFAs have on brain function, behaviour and physiology, which will inform future microbiota-targeted interventions for brain disorders.
AB - The role of the intestinal microbiota as a regulator of gut-brain axis signalling has risen to prominence in recent years. Understanding the relationship between the gut microbiota, the metabolites it produces, and the brain will be critical for the subsequent development of new therapeutic approaches, including the identification of novel psychobiotics. A key focus in this regard have been the short-chain fatty acids (SCFAs) produced by bacterial fermentation of dietary fibre, which include butyrate, acetate, and propionate. Ongoing research is focused on the entry of SCFAs into systemic circulation from the gut lumen, their migration to cerebral circulation and across the blood brain barrier, and their potential to exert acute and chronic effects on brain structure and function. This review aims to discuss our current mechanistic understanding of the direct and indirect influence that SCFAs have on brain function, behaviour and physiology, which will inform future microbiota-targeted interventions for brain disorders.
KW - Microbiome
KW - Microbiota
KW - Microbiota-gut-brain axis
KW - Short-chain fatty acids
UR - https://www.scopus.com/pages/publications/85123596152
U2 - 10.1016/j.mce.2022.111572
DO - 10.1016/j.mce.2022.111572
M3 - Review article
C2 - 35066114
AN - SCOPUS:85123596152
SN - 0303-7207
VL - 546
JO - Molecular and Cellular Endocrinology
JF - Molecular and Cellular Endocrinology
M1 - 111572
ER -